Apyx Medical (APYX) Analyst & Key Data

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

8

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

D+

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.90

Median Target+118.28%

$6.33

Potential upside vs current price

DCF Value-270.05%

-$4.93

Potential downside vs current price

Current Stock Price

$2.90

Median Target+118.28%

$6.33

Potential upside vs current price

DCF Value-270.05%

-$4.93

Potential downside vs current price

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

8

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

D+

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.90

Median Target+118.28%

$6.33

Potential upside vs current price

DCF Value-270.05%

-$4.93

Potential downside vs current price

Current Stock Price

$2.90

Median Target+118.28%

$6.33

Potential upside vs current price

DCF Value-270.05%

-$4.93

Potential downside vs current price

Apyx Medical Corporation